⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACXP News
Acurx Pharmaceuticals, Inc. Common Stock
Acurx Announces New Data on its DNA pol IIIC Inhibitor Antibiotics Demonstrating a Potential Class Effect of Gut Microbiome Selectivity Presented at IDWeek 2025 Scientific Conference
prnewswire.com
ACXP
Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update
prnewswire.com
ACXP
New to The Street to Broadcast Nationwide on Bloomberg TV Tonight at 6:30 PM EST Featuring Roadzen, Spartan Equipment, XION, Metaterra, and YY Group
accessnewswire.com
LASE
AERT
ACXP
DVLT
YYGH
Meet the Companies - New to The Street's Accredited Investor Event Returns October 21-22 at Hudson Yards, NYC
accessnewswire.com
SNYR
DVLT
ACXP
RDZN
AREB
MUSQ
NTHI
Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors
prnewswire.com
ACXP
New to The Street to Broadcast Tonight on Fox Business 10:30 PM PST Featuring NeOnc Technologies, FLOKI, XION, Sharps Technology, and Aeries Technology
accessnewswire.com
NTHI
STSS
AERT
LASE
SNYR
AERT
ACXP
New to The Street to Broadcast Nationwide on Bloomberg Tonight at 6:30 PM EST
accessnewswire.com
LASE
ACXP
PETV
DVLT
CISO
LASE
ACXP
PETV
DVLT
Acurx Announces Positive Opinion from EMA on Pediatric Investigation Plan for Ibezapolstat Use in Children with C. difficile Infection
prnewswire.com
ACXP
New to The Street to Broadcast Saturday, September 27th Featuring NeOnc Pharma $NTHI and Other Innovative Companies
accessnewswire.com
NTHI
STSS
AERT
LASE
ACXP
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events
accessnewswire.com
ACXP
ACXP